Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Anesthesiology
Published in: BMC Anesthesiology 1/2017

Open Access 01-12-2017 | Research article

Effects and mechanism of dexmedetomidine on neuronal cell injury induced by hypoxia-ischemia

Authors: Ya-Jun Liu, Duan-Yu Wang, Yong-Jian Yang, Wei-Fu Lei

Published in: BMC Anesthesiology | Issue 1/2017

Login to get access

Abstract

Background

The present study aims to investigate the protective effects of dexmedetomidine (DMED) on hypoxia ischemia injury induced by oxygen and glucose deprivation (OGD) in PC12 and primary neuronal cells.

Methods

PC12 cells exposed to OGD was used to establish ischemia model. The OGD-induced cell injury was evaluated by alterations of cell viability, apoptosis and expressions of apoptosis-associated proteins. Oxidative stress and expressions of neurotrophic factors after OGD and DMED treatments were also explored. The activation of possible involved signaling pathways were studied after OGD and DMED treatments, along with the addition of inhibitors of these pathways. Finally, the effects of DMED on primary neuronal cells were verified according to the alterations of inflammatory cytokines release and oxidative stress.

Results

DMED obviously increased cell viability and reduced cell apoptosis as well as ratio of Bax/Bcl-2 in OGD-treated PC12 cells. Then, the OGD-induced changes of LDH, MDA, SOD and GSH-Px as well as decreases of neurotrophic factors were all ameliorated by DMED treatment. Key kinases in Notch/NF-κB signaling pathway were up-regulated by OGD, whereas the up-regulations were decreased by DMED. In addition, inhibitor of Notch or NF-κB could augment the effects of DMED on OGD-induced cell injury. Finally, the protective effects of DMED were verified in primary neuronal cells.

Conclusion

DMED had protective effect on OGD-induced PC12 cell injury, depending on its anti-apoptotic, anti-oxidative activity and the inhibition of Notch/NF-κB activation. Our findings suggested that DMED could be used as a potential therapeutic drug for cerebral ischemia.
Literature
1.
Maier O, Menze BH, Gablentz JVD, Häni L, Heinrich MP, Liebrand M, Winzeck S, Basit A, Bentley P, Chen L. ISLES 2015 - A public evaluation benchmark for ischemic stroke lesion segmentation from multispectral MRI. Med Image Anal. 2017;35:250.CrossRefPubMed
2.
Shi Z, Wu D, Yao J-P, Yao X, Huang Z, Li P, Wan J-B, He C, Su H. Protection against oxygen-glucose deprivation/reperfusion injury in cortical neurons by combining omega-3 polyunsaturated acid with lyciumbarbarum polysaccharide. Nutrients. 2016;8(1):41.CrossRefPubMedCentral
3.
Seidenstein MAH, Barone FC, Lytton WW. Computer modeling of ischemic stroke. Drug Discov Today Dis Models. 2017;10(3):32015.
4.
Chao G, Wang S, Duan J, Na J, Zhu Y, Yi D, Yue G, Guo W, Ying Y, Xi M. Protocatechualdehyde protects against cerebral ischemia-reperfusion-induced oxidative injury via protein Kinase Cε/Nrf2/HO-1 pathway. Mol Neurobiol. 2017;54(2):833.CrossRef
5.
Meng S, Su Z, Liu Z, Wang N, Wang Z. Rac1 contributes to cerebral ischemia reperfusion-induced injury in mice by regulation of Notch2. Neuroscience. 2015;306:100–14.CrossRefPubMed
6.
Li P, Shen M, Feng G, Wu J, Zhang J, Teng F, Zhang C. An antagomir to MicroRNA-106b-5p ameliorates cerebral ischemia and reperfusion injury in rats via inhibiting apoptosis and oxidative stress. Mol Neurobiol. 2017;54(4):2901–21.
7.
Zhao JH, Meng XL, Zhang J, Li YL, Li YJ, Fan ZM. Oxygen glucose deprivation post-conditioning protects cortical neurons against oxygen-glucose deprivation injury: role of HSP70 and inhibition of apoptosis. J Huazhong Univ Sci Technolog Med Sci. 2014;34(1):18–22.CrossRefPubMed
8.
Ryu S, Seol GH, Park H, Choi IY. Trans-anethole protects cortical neuronal cells against oxygen-glucose deprivation/reoxygenation. Neurol Sci. 2014;35(10):1541–7.CrossRefPubMed
9.
Tasca CI, Dal-Cim T, Cimarosti H. In vitro oxygen-glucose deprivation to study ischemic cell death. Methods Mol Biol. 2015;1254:197–210.CrossRefPubMed
10.
Vaudry D, Stork PJ, Lazarovici P, Eiden LE. Signaling pathways for PC12 cell differentiation: making the right connections. Science (New York, NY). 2002;296(5573):1648–9.CrossRef
11.
Hillion JA, Takahashi K, Maric D, Ruetzler C, Barker JL, Hallenbeck JM. Development of an ischemic tolerance model in a PC12 cell line. J Cereb Blood Flow Metab. 2005;25(2):154–62.CrossRefPubMedPubMedCentral
12.
Shafer TJ, Atchison WD. Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies. Neurotoxicology. 1991;12(3):473–92.PubMed
13.
Fu XY, Yang MF, Cao MZ, Li DW, Yang XY, Sun JY, Zhang ZY, Mao LL, Zhang S, Wang FZ. Strategy to suppress oxidative damage-induced neurotoxicity in PC12 cells by Curcumin: the role of ROS-mediated DNA damage and the MAPK and AKT pathways. Mol Neurobiol. 2016;53(1):369–78.CrossRefPubMed
14.
Zhang D, Wang Z, Sheng C, Peng W, Shan H, Wei G, Chen S. Icariin prevents amyloid beta-induced apoptosis via the PI3K/Akt pathway in PC-12 cells. Evid Based Complement Alternat Med. 2015;2015:235265.PubMedPubMedCentral
15.
Leutz S, Steiner B, Marques CA, Haass C, Muller WE, Eckert A. Reduction of trophic support enhances apoptosis in PC12 cells expressing Alzheimer’s APP mutation and sensitizes cells to staurosporine-induced cell death. J Mol Neurosci. 2002;18(3):189–201.CrossRefPubMed
16.
Endesfelder S, Makki H, Haefen CV, Spies CD, Bührer C, Sifringer M. Neuroprotective effects of dexmedetomidine against hyperoxia-induced injury in the developing rat brain. PLoS One. 2017;12(2):e0171498.CrossRefPubMedPubMedCentral
17.
Jie L, Wei O, Zou XH, Yin Y, Wu JL. Effect of dexmedetomidine on hippocampal neuron development and BDNF-TrkB signal expression in neonatal rats. Neuropsychiatr Dis Treat. 2016;12:3153–9.CrossRef
18.
Prielipp RC, Wall MH, Tobin JR, Groban L, Cannon MA, Fahey FH, Gage HD, Stump DA, James RL, Bennett J, et al. Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow. Anesth Analg. 2002;95(4):1052–9. table of contentsPubMed
19.
Liu J, Du Q, Zhu H, Li Y, Liu M, Yu S, Wang S. Dexmedetomidine reduces hypoxia/reoxygenation injury by regulating mitochondrial fission in rat hippocampal neurons. Int J Clin Exp Med. 2017;10(4):6861–8.
20.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1–2):55–63.CrossRefPubMed
21.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001;25(4):402–8.CrossRefPubMed
22.
Esmat AY, Said MM, Khalil SA. Aloin: a natural antitumor anthraquinone glycoside with iron chelating and non-atherogenic activities. Pharm Biol. 2015;53(1):138–46.CrossRefPubMed
23.
Hong S, Son MR, Yun K, Lee WT, Park KA, Lee JE. Retroviral expression of human arginine decarboxylase reduces oxidative stress injury in mouse cortical astrocytes. BMC Neurosci. 2014;15:99.CrossRefPubMedPubMedCentral
24.
Tan JA, Ho KM. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intensive Care Med. 2010;36(6):926–39.CrossRefPubMed
25.
Farag E, Argalious M, Abd-Elsayed A, Ebrahim Z, Doyle DJ. The use of dexmedetomidine in anesthesia and intensive care: a review. Curr Pharm Des. 2012;18(38):6257–65.CrossRefPubMed
26.
Dahmani S, Rouelle D, Gressens P, Mantz J. Effects of dexmedetomidine on hippocampal focal adhesion kinase tyrosine phosphorylation in physiologic and ischemic conditions. Anesthesiology. 2005;103(5):969–77.CrossRefPubMed
27.
Wu JB, Song NN, Wei XB, Guan HS, Zhang XM. Protective effects of paeonol on cultured rat hippocampal neurons against oxygen-glucose deprivation-induced injury. J Neurol Sci. 2008;264(1–2):50–5.CrossRefPubMed
28.
Xu W, Zha RP, Wang WY, Wang YP. Effects of scutellarin on PKCgamma in PC12 cell injury induced by oxygen and glucose deprivation. Acta Pharmacol Sin. 2007;28(10):1573–9.CrossRefPubMed
29.
30.
Vannucci RC, Towfighi J, Vannucci SJ. Secondary energy failure after cerebral hypoxia-ischemia in the immature rat. J Cereb Blood Flow Metab. 2004;24(10):1090–7.CrossRefPubMed
31.
32.
Qin H, Tan W, Zhang Z, Bao L, Shen H, Wang F, Xu F, Wang Z. 15d-prostaglandin J2 protects cortical neurons against oxygen-glucose deprivation/reoxygenation injury: involvement of inhibiting autophagy through upregulation of Bcl-2. Cell Mol Neurobiol. 2015;35(3):303–12.CrossRefPubMed
33.
Chong ZZ, Li F, Maiese K. Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol. 2005;75(3):207–46.CrossRefPubMed
34.
Korenic A, Boltze J, Deten A, Peters M, Andjus P, Radenovic L. Astrocytic mitochondrial membrane hyperpolarization following extended oxygen and glucose deprivation. PLoS One. 2014;9(2):e90697.CrossRefPubMedPubMedCentral
35.
Yanpallewar SU, Rai S, Kumar M, Acharya SB. Evaluation of antioxidant and neuroprotective effect of Ocimum sanctum on transient cerebral ischemia and long-term cerebral hypoperfusion. Pharmacol Biochem Behav. 2004;79(1):155–64.CrossRefPubMed
36.
Ivanov AD, Tukhbatova GR, Salozhin SV, Markevich VA. NGF but not BDNF overexpression protects hippocampal LTP from β-amyloid-induced impairment. Neuroscience. 2015;289:114–22.CrossRefPubMed
37.
Liu F, Xuan A, Chen Y, Zhang J, Xu L, Yan Q, Long D. Combined effect of nerve growth factor and brain鈥慸erived neurotrophic factor on neuronal differentiation of neural stem cells and the potential molecular mechanisms. Mol Med Rep. 2014;10(4):1739–45.CrossRefPubMedPubMedCentral
38.
Maillard I, Fang T, Pear WS. Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu Rev Immunol. 2005;23:945–74.CrossRefPubMed
39.
Andersson ER, Sandberg R, Lendahl U. Notch signaling: simplicity in design, versatility in function. Development (Cambridge, England). 2011;138(17):3593–612.CrossRef
40.
Espinosa L, Cathelin S, D'Altri T, Trimarchi T, Statnikov A, Guiu J, Rodilla V, Ingles-Esteve J, Nomdedeu J, Bellosillo B, et al. The Notch/Hes1 pathway sustains NF-kappaB activation through CYLD repression in T cell leukemia. Cancer Cell. 2010;18(3):268–81.CrossRefPubMedPubMedCentral
41.
Screpanti I, Bellavia D, Campese AF, Frati L, Gulino A. Notch, a unifying target in T-cell acute lymphoblastic leukemia? Trends Mol Med. 2003;9(1):30–5.CrossRefPubMed
42.
Zhao C, Liu J, Zhang M, Wu Y. Semaphorin 3A deficiency improves hypoxia-induced myocardial injury via resisting inflammation and cardiomyocytes apoptosis. Cellular Mol Biol (Noisy-le-Grand, France). 2016;62(2):8.
43.
Dickinson BC, Peltier J, Stone D, Schaffer DV, Chang CJ. Nox2 redox signaling maintains essential cell populations in the brain. Nat Chem Biol. 2011;7(2):106–12.CrossRefPubMed
44.
Goshan V, Mundugaru R, Prakash N, Bhat S, Basavaiah R: Evaluation of neuro-protective activity of Brihatvata Chinthamani Rasa. 2015.
Metadata
Title
Effects and mechanism of dexmedetomidine on neuronal cell injury induced by hypoxia-ischemia
Authors
Ya-Jun Liu
Duan-Yu Wang
Yong-Jian Yang
Wei-Fu Lei
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Anesthesiology / Issue 1/2017
Electronic ISSN: 1471-2253
DOI
https://doi.org/10.1186/s12871-017-0413-4

Other articles of this Issue 1/2017

BMC Anesthesiology 1/2017 Go to the issue

Research article

Propofol inhibits the release of interleukin-6, 8 and tumor necrosis factor-α correlating with high-mobility group box 1 expression in lipopolysaccharides-stimulated RAW 264.7 cells

Research article

Detection of critical cerebral desaturation thresholds by three regional oximeters during hypoxia: a pilot study in healthy volunteers

Research article

Evaluation of the optimal cuff volume and cuff pressure of the revised laryngeal tube “LTS-D” in surgical patients

Research article

Retrospective case-control non-inferiority analysis of intravenous lidocaine in a colorectal surgery enhanced recovery program

Erratum

Erratum to: Lipid emulsion mitigates impaired pulmonary function induced by limb I/R in rats through attenuation of local cellular injury and the subsequent systemic inflammatory response/inflammation

Research article

Validation of the imperial college surgical assessment device for spinal anesthesia